Deb Lancaster Email & Phone Number

Views are my own and not reflective of those of of my employerMore than 10 years experience as a Pharma ELT member, 25 years experience in oncology, and 37 years experience in the Pharma industry. Moved to public sector in 2021 for a different perspective - reflecting changes in my life, focussing more on my values.• Experienced ELT member and pharma industry leader with proven ability to recruit, build, develop and motivate high performing expert teams. Positive and authentic leadership style with integrity and insight, and a desire to always deliver the best possible outcome for the business as well as for the people comprising it. Able to establish strong and effective business relationships influencing senior leaders internally and externally by effectively and clearly communicating strategy, policies and plans. Calm under pressure, able to handle crises effectively and to trust team members to do the right thing.• Strategic deliverer: Ability to make a concrete difference and deliver revenue targets: consistently develop, articulate and action key strategic decisions, able to decipher and process information quickly and think clearly. Decisive – drives for results, able to accept and handle ambiguity. Adaptable and fast-learning, focused on tangible outcomes achieved through collaboration both internally and externally. Able to motivate and focus teams to meet key business drivers whilst ensuring engagement of key talent.• Extensive experience in market access, insight & analysis, operations, sales and marketing leadership and as media/parliamentary spokesperson. Can handle and simplify complex information effectively – analyse situations, gain insights quickly and comprehensively, provide clarity and focus on a few key priorities.• Experienced change agent, able to quickly and successfully refocus strategy to meet evolving business requirements and bring stakeholders along with the change.

Listed skills include Oncology, Pharmaceutical Industry, Pharmaceutical Sales, Cardiology, and 30 others.